PartnershipJun 9, 2026, 07:01 AM
Aclarion Partners with PRIA Healthcare for Nociscan US Market Access
AI Summary
Aclarion, Inc. announced a Market Access Program in partnership with PRIA Healthcare to advance its Nociscan® AI-driven platform for chronic low back pain through the U.S. reimbursement process. This initiative aims to expand patient access and support commercial adoption, leveraging PRIA Healthcare's expertise in payer engagement and prior authorization. The company notes Nociscan's prior success in the UK, where it secured payer approval from three of the top four private insurers, as a strong foundation for its U.S. strategy.
Key Highlights
- Aclarion launched a Market Access Program in partnership with PRIA Healthcare for Nociscan®.
- The program aims to advance Nociscan through the reimbursement process for U.S. commercial expansion.
- PRIA Healthcare will provide expertise in payer engagement, prior authorization support, and appeals management.
- Nociscan has achieved payer approval from three of the top four private insurance companies in the United Kingdom.
- The initiative is a pivotal step in Aclarion's commercialization plan to support scalable growth.
Price Impact
More from ACON